These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 2157675)

  • 21. Role of DNA content analysis and immunohistochemistry in the evaluation of the risk of unfavourable outcome in Wilms' tumours.
    Osterheld MC; Caron L; Meagher-Villemure K
    Anticancer Res; 2008; 28(2A):751-6. PubMed ID: 18507016
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nuclear accumulation of beta-catenin protein in Wilms' tumours.
    Koesters R; Niggli F; von Knebel Doeberitz M; Stallmach T
    J Pathol; 2003 Jan; 199(1):68-76. PubMed ID: 12474228
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nuclear DNA content of non-endemic Burkitt's lymphoma.
    Lehtinen T; Lehtinen M; Aine R; Kallioniemi OP; Leino T; Hakala T; Leinikki P; Alavaikko M
    J Clin Pathol; 1987 Oct; 40(10):1201-5. PubMed ID: 3680544
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Recent update on tumour biology and treatment of Merkel Cell carcinoma].
    Steinstraesser L; Kueckelhaus M; Koljonen V
    Handchir Mikrochir Plast Chir; 2011 Dec; 43(6):345-9. PubMed ID: 22241518
    [TBL] [Abstract][Full Text] [Related]  

  • 25. WTX mutations can occur both early and late in the pathogenesis of Wilms tumour.
    Fukuzawa R; Holman SK; Chow CW; Savarirayan R; Reeve AE; Robertson SP
    J Med Genet; 2010 Nov; 47(11):791-4. PubMed ID: 20679664
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Update on Merkel Cell Carcinoma.
    Harms PW
    Clin Lab Med; 2017 Sep; 37(3):485-501. PubMed ID: 28802497
    [TBL] [Abstract][Full Text] [Related]  

  • 27. V(H) gene analysis of Burkitt's lymphoma in children from north-western Iran.
    Chapman CJ; Wright D; Feizi HP; Davis Z; Stevenson FK
    Br J Haematol; 1998 Dec; 103(4):1116-23. PubMed ID: 9886329
    [TBL] [Abstract][Full Text] [Related]  

  • 28. BRAF gene is somatically mutated but does not make a major contribution to malignant melanoma susceptibility: the Italian Melanoma Intergroup Study.
    Casula M; Colombino M; Satta MP; Cossu A; Ascierto PA; Bianchi-Scarrà G; Castiglia D; Budroni M; Rozzo C; Manca A; Lissia A; Carboni A; Petretto E; Satriano SM; Botti G; Mantelli M; Ghiorzo P; Stratton MR; Tanda F; Palmieri G;
    J Clin Oncol; 2004 Jan; 22(2):286-92. PubMed ID: 14722037
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Insight into Burkitt's lymphoma from immunoglobulin variable region gene analysis.
    Chapman CJ; Wright D; Stevenson FK
    Leuk Lymphoma; 1998 Jul; 30(3-4):257-67. PubMed ID: 9713958
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Loss of heterozygosity at 11p13 in Wilms' tumours does not necessarily involve mutations in the WT1 gene.
    Cowell JK; Groves N; Baird P
    Br J Cancer; 1993 Jun; 67(6):1259-61. PubMed ID: 8390282
    [TBL] [Abstract][Full Text] [Related]  

  • 31. VH gene analysis in sporadic Burkitt's lymphoma: somatic mutation and intraclonal diversity with special reference to the tumor cells involving germinal center.
    Isobe K; Tamaru J; Nakamura S; Harigaya K; Mikata A; Ito H
    Leuk Lymphoma; 2002 Jan; 43(1):159-64. PubMed ID: 11908722
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Frequent allelic loss at 10q23 but low incidence of PTEN mutations in Merkel cell carcinoma.
    Van Gele M; Leonard JH; Van Roy N; Cook AL; De Paepe A; Speleman F
    Int J Cancer; 2001 May; 92(3):409-13. PubMed ID: 11291079
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Use of DNA polymorphism detected by M13 phage DNA in population studies].
    Barysheva EV; Bukina AM; Petrova NV; Limborskaia SA; Ginter EK
    Genetika; 1991 Mar; 27(3):399-403. PubMed ID: 1830281
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mutational landscape of MCPyV-positive and MCPyV-negative Merkel cell carcinomas with implications for immunotherapy.
    Goh G; Walradt T; Markarov V; Blom A; Riaz N; Doumani R; Stafstrom K; Moshiri A; Yelistratova L; Levinsohn J; Chan TA; Nghiem P; Lifton RP; Choi J
    Oncotarget; 2016 Jan; 7(3):3403-15. PubMed ID: 26655088
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recurrent mutation of immunoglobulin and c-myc genes and differential expression of cell surface antigens occur in variant cell lines derived from a Burkitt lymphoma.
    Guy K; Middleton PG; Bansal NS; Ross JA; Steel CM
    Int J Cancer; 1990 Jan; 45(1):109-18. PubMed ID: 2298494
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Letter: Burkitt's lymphoma.
    Innis MD
    Med J Aust; 1974 Apr; 1(16):637-8. PubMed ID: 4365306
    [No Abstract]   [Full Text] [Related]  

  • 37. Topoisomerase IIalpha in Wilms' tumour: gene alterations and immunoexpression.
    Tretiakova M; Turkyilmaz M; Grushko T; Kocherginsky M; Rubin C; Teh B; Yang XJ
    J Clin Pathol; 2006 Dec; 59(12):1272-7. PubMed ID: 16556665
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Genomic fingerprints of organisms from different taxonomic groups: the use of phage M13 DNA as a hybridization probe].
    Ryskov AP; Dzhincharadze AG; Prosnik MI; Ivanov PL; Limborskaia SA
    Genetika; 1988 Feb; 24(2):227-38. PubMed ID: 3282990
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PI3-kinase subunits are infrequent somatic targets in melanoma.
    Curtin JA; Stark MS; Pinkel D; Hayward NK; Bastian BC
    J Invest Dermatol; 2006 Jul; 126(7):1660-3. PubMed ID: 16614723
    [No Abstract]   [Full Text] [Related]  

  • 40. Development of homozygosity for chromosome 11p markers in Wilms' tumour.
    Orkin SH; Goldman DS; Sallan SE
    Nature; 1984 May 10-16; 309(5964):172-4. PubMed ID: 6325937
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.